171 related articles for article (PubMed ID: 26602178)
1. Cost-effectiveness of multiparametric magnetic resonance imaging and targeted biopsy in diagnosing prostate cancer.
Cerantola Y; Dragomir A; Tanguay S; Bladou F; Aprikian A; Kassouf W
Urol Oncol; 2016 Mar; 34(3):119.e1-9. PubMed ID: 26602178
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.
de Rooij M; Crienen S; Witjes JA; Barentsz JO; Rovers MM; Grutters JP
Eur Urol; 2014 Sep; 66(3):430-6. PubMed ID: 24377803
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
[TBL] [Abstract][Full Text] [Related]
4. The Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Men with Low-risk Prostate Cancer: A Cost-effectiveness Modeling Study.
Patel S; Rongen JJ; Fütterer JJ; Boltyenkov A; Rovers MM
Eur Urol Oncol; 2018 Dec; 1(6):476-483. PubMed ID: 31158091
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer.
Panebianco V; Valerio MC; Giuliani A; Pecoraro M; Ceravolo I; Barchetti G; Catalano C; Padhani AR
Eur Urol Oncol; 2018 Aug; 1(3):208-214. PubMed ID: 31102623
[TBL] [Abstract][Full Text] [Related]
6. Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS).
Faria R; Soares MO; Spackman E; Ahmed HU; Brown LC; Kaplan R; Emberton M; Sculpher MJ
Eur Urol; 2018 Jan; 73(1):23-30. PubMed ID: 28935163
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer.
Barnett CL; Davenport MS; Montgomery JS; Wei JT; Montie JE; Denton BT
BJU Int; 2018 Jul; 122(1):50-58. PubMed ID: 29388388
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of MR Imaging-guided Strategies for Detection of Prostate Cancer in Biopsy-Naive Men.
Pahwa S; Schiltz NK; Ponsky LE; Lu Z; Griswold MA; Gulani V
Radiology; 2017 Oct; 285(1):157-166. PubMed ID: 28514203
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness Comparison of Imaging-Guided Prostate Biopsy Techniques: Systematic Transrectal Ultrasound, Direct In-Bore MRI, and Image Fusion.
Venderink W; Govers TM; de Rooij M; Fütterer JJ; Sedelaar JPM
AJR Am J Roentgenol; 2017 May; 208(5):1058-1063. PubMed ID: 28225639
[TBL] [Abstract][Full Text] [Related]
10. Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy.
Lotan Y; Haddad AQ; Costa DN; Pedrosa I; Rofsky NM; Roehrborn CG
Urol Oncol; 2015 Jun; 33(6):266.e9-16. PubMed ID: 25858102
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.
Sathianathen NJ; Konety BR; Alarid-Escudero F; Lawrentschuk N; Bolton DM; Kuntz KM
Eur Urol; 2019 Jun; 75(6):910-917. PubMed ID: 30425010
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of multiparametric magnetic resonance imaging and MRI-guided biopsy in a population-based prostate cancer screening setting using a micro-simulation model.
Getaneh AM; Heijnsdijk EA; de Koning HJ
Cancer Med; 2021 Jun; 10(12):4046-4053. PubMed ID: 33991077
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer diagnostic pathway: Is a one-stop cognitive MRI targeted biopsy service a realistic goal in everyday practice? A pilot cohort in a tertiary referral centre in the UK.
Bass EJ; Freeman A; Jameson C; Punwani S; Moore CM; Arya M; Emberton M; Ahmed HU
BMJ Open; 2018 Oct; 8(10):e024941. PubMed ID: 30361408
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of cognitive MRI-targeted biopsy in hitting prostate cancer-positive regions of interest.
Cerantola Y; Haberer E; Torres J; Alameldin M; Aronson S; Levental M; Bladou F; Anidjar M
World J Urol; 2016 Jan; 34(1):75-82. PubMed ID: 25981403
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia.
Gordon LG; James R; Tuffaha HW; Lowe A; Yaxley J
J Magn Reson Imaging; 2017 May; 45(5):1304-1315. PubMed ID: 27726240
[TBL] [Abstract][Full Text] [Related]
16. Yield of concurrent systemic biopsy during MRI-targeted biopsy according to Prostate Imaging Reporting and Data System version 2 in patients with suspected prostate cancer.
Kim CH; Kim CK; Park JJ; Park SY; Yoon YC
Eur Radiol; 2021 Mar; 31(3):1667-1675. PubMed ID: 32910231
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging-targeted vs. conventional transrectal ultrasound-guided prostate biopsy: single-institution, matched cohort comparison.
Kim EH; Vemana G; Johnson MH; Vetter JM; Rensing AJ; Strother MC; Fowler KJ; Andriole GL
Urol Oncol; 2015 Mar; 33(3):109.e1-6. PubMed ID: 25655682
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric magnetic resonance imaging-targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results.
Abdi H; Zargar H; Goldenberg SL; Walshe T; Pourmalek F; Eddy C; Chang SD; Gleave ME; Harris AC; So AI; Machan L; Black PC
Urol Oncol; 2015 Apr; 33(4):165.e1-7. PubMed ID: 25665509
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
[TBL] [Abstract][Full Text] [Related]
20. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H
Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
